Metabolic syndrome and carotid intima media thickness in the Health 2000 Survey

Atherosclerosis

Volumn 204, Issue 1, 2009, Pages 276-281

  Sipilä, Kalle ^a   Moilanen, Leena ^b   Nieminen, Tuomo ^c   Reunanen, Antti ^d   Jula, Antti ^d   Salomaa, Veikko ^d   Kaaja, Risto ^e   Kukkonen Harjula, Katriina ^f   Lehtimäki, Terho ^a   Kesäniemi, Y Antero ^g   Koivistoinen, Teemu ^c   Nieminen, Markku S ^h   Tuomilehto, Jaakko ^h,i   Kähönen, Mika ^a,c  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f UKK INSTITUTE FOR HEALTH PROMOTION RESEARCH   (Finland)

^g UNIVERSITY OF OULU   (Finland)

^h UNIVERSITY OF HELSINKI   (Finland)

ⁱ SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

Author keywords

Carotid atherosclerosis; Carotid intima media thickness; Metabolic syndrome; Risk factors; Sex

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; BODY MASS; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; EDUCATION PROGRAM; FEMALE; FINLAND; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SEX DETERMINATION; SMOKING; WAIST CIRCUMFERENCE;

AGED; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; HEALTH SURVEYS; HUMANS; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 67349168110     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.08.029     Document Type: Article

References (31)

1. Lorenzo C., et al. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 26 (2003) 3153-3159
2. Bonora E., et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care 26 (2003) 1251-1257
3. Malik S., Wong N.D., Franklin S.S., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110 (2004) 1245-1250
4. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
5. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
7. Bots M.L., Hoes A.W., Koudstaal P.J., Hofman A., and Grobbee D.E. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 96 (1997) 1432-1437
8. O'Leary D.H., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 340 (1999) 14-22
9. Chambless L.E., Heiss G., Folsom A.R., et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 146 (1997) 483-494
10. Staub D., Meyerhans A., Bundi B., Schmid H.P., and Frauchiger B. Prediction of cardiovascular morbidity and mortality: comparison of the internal carotid artery resistive index with the common carotid artery intima-media thickness. Stroke 37 (2006) 800-805
11. Hulthe J., Bokemark L., Wikstrand J., and Fagerberg B. The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study. Arterioscler Thromb Vasc Biol 20 (2000) 2140-2147
12. Anand S.S., et al. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 108 (2003) 420-425
13. Scuteri A., Najjar S.S., Muller D.C., et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 43 (2004) 1388-1395
14. McNeill A.M., Rosamond W.D., Girman C.J., et al. Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study). Am J Cardiol 94 (2004) 1249-1254
15. Ahluwalia N., Drouet L., Ruidavets J.B., et al. Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample. Atherosclerosis 186 (2006) 345-353
16. Skilton M.R., Moulin P., Serusclat A., Nony P., and Bonnet F. A comparison of the NCEP-ATPIII, IDF and AHA/NHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: evidence for sex-specific differences. Atherosclerosis 190 (2007) 416-422
17. Iglseder B., Cip P., Malaimare L., Ladurner G., and Paulweber B. The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke 36 (2005) 1212-1217
18. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
19. Hassinen M., Komulainen P., Lakka T.A., et al. Metabolic syndrome and the progression of carotid intima-media thickness in elderly women. Arch Intern Med 166 (2006) 444-449
20. Teramura M., Emoto M., Araki T., et al. Clinical impact of metabolic syndrome by modified NCEP-ATP III criteria on carotid atherosclerosis in Japanese adults. J Atheroscler Thromb 14 (2007) 172-178
21. Aromaa A, Koskinen S,editors. Health and functional capacity in Finland. Baseline results of the Health 2000 Health Examination Survey. Helsinki: Publications of the National Public Health Institute B12/2004; 2004. Available at: www.ktl.fi/health2000. Accessed October 15, 2004.
22. Grundy S.M., Hansen B., Smith Jr. S.C., Cleeman J.I., and Kahn R.A. American Heart Association, National Heart, Lung, and Blood Institute, American Diabetes Association. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109 (2004) 551-556
23. Niiranen T., Jula A., Kantola I., et al. Home-measured blood pressure is more strongly associated with atherosclerosis than clinic blood pressure: the Finn-HOME Study. J Hypertens 25 (2007) 1225-1231
24. Seidell J.C., Kahn H.S., Williamson D.F., Lissner L., and Valdez R. Report from a Center for Disease Control and Prevention Workshop on use of adult anthropometry for public health and primary health care. Am J Clin Nutr 73 (2001) 123-126
25. Grebe M.T., Schoene E., Schaefer C.A., et al. Elevated lipoprotein(a) does not promote early atherosclerotic changes of the carotid arteries in young, healthy adults. Atherosclerosis 190 (2007) 194-198
26. Hedblad B., et al. Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmo, Sweden. Diabet Med 17 (2000) 299-307
27. Kawamoto R., Tomita H., Oka Y., Kodama A., and Kamitani A. Metabolic syndrome amplifies the LDL-cholesterol associated increases in carotid atherosclerosis. Intern Med 44 (2005) 1232-1238
28. Nishida M., Moriyama T., Ishii K., et al. Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis. Clin Chim Acta 384 (2007) 99-104
29. Czernichow S., et al. Metabolic syndrome in relation to structure and function of large arteries: a predominant effect of blood pressure. A report from the SU. VI. MAX. Vascular Study. Am J Hypertens 18 (2005) 1154-1160
30. Empana J.P., Zureik M., Gariepy J., et al. The metabolic syndrome and the carotid artery structure in noninstitutionalized elderly subjects: the three-city study. Stroke 38 (2007) 893-899
31. Cuspidi C., Meani S., Valerio, et al. Age and target organ damage in essential hypertension: role of the metabolic syndrome. Am J Hypertens 20 (2007) 296-303